04.09.24
Huningue, France – Firalis Molecular Precision (FMP), a CAP-accredited fast-growing Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), proudly announces its attainment of ISO 20387:2018 certification, a significant milestone underscoring FMP’s commitment to high quality in biobanking practices.
ISO 20387:2018, an internationally recognized standard, sets forth stringent requirements for the competence, impartiality, and consistent operation of biobanks engaged in the collection, processing, storage, and distribution of biological materials and associated data for research and development purposes.
This certification validates FMP’s adherence to the highest quality standards in all facets of its biobanking operations. By complying with ISO 20387, FMP ensures the integrity, reliability, and traceability of biological samples, thereby bolstering confidence in research outcomes and fostering collaboration among biobanks and researchers globally.
It also further enriches Firalis Molecular Precision’s extensive certificate portfolio, reaffirming its dedication to delivering high-quality services and solutions to its clients.
For more information about FMP’s Quality Management System and its ISO 20387:2018 certification (N° 2024/108791.1), visit firalismolecularprecision.com/quality-management-and-standards
About Firalis Molecular Precision
Firalis Molecular Precision (FMP) is a fast-growing CRO & CDMO, providing advanced multi-omics solutions and tailored contract research services to the Life Sciences sector.
With headquarters in Huningue, France, and a presence in Cambridge, Mass., FMP is renowned for its commitment to innovation and excellence.
Leveraging cutting-edge technologies, FMP offers a comprehensive suite of bioanalytical services encompassing biobanking, multiomics-driven analyses (including genomics, proteomics, transcriptomics, lipidomics, and metabolomics), as well as omic data analysis, assay development, and custom in vitro diagnostic (IVD) kit manufacturing.
FMP’s mission is to empower healthcare professionals, researchers, and biopharmaceutical entities with the tools and solutions they need to drive progress towards better patient care and a more personalized medicine.